New study aims to predict kidney cancer outcomes more accurately
NCT ID NCT07117227
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses data from 4,700 kidney cancer patients treated at a single hospital over 12 years. The goal is to create a new model that better predicts how the disease will progress, especially for patients with a tumor thrombus. Researchers will also test whether using this model to guide treatment decisions could improve survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate way to predict outcomes for kidney cancer patients, helping doctors choose the right treatment for each person.
- What could go wrong
- This is an observational study, not a treatment trial. The model may not work as well in other hospitals or patient groups, and it does not test a new drug or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSERVATIONAL STUDY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100191, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do blood thinners help or hurt when cancer meets a clot?
- New imaging agent aims to spot Hard-to-Find kidney cancer spread
- Triple therapy takes on rare, aggressive kidney cancer
- Can fasting two days a week slow kidney cancer? a new trial tests the idea
- Nerve block may slash opioid use after kidney surgery
- Can a chess champion film inspire kenyan teens to aim higher?